Tieteelliset julkaisut

Preclinical evaluation of phenotypic mariAST MRSA RUO test against routine MRSA screening methods in hospital setting. Antikainen P, et al. 28th European Congress of Clinical Microbiology and Infectious Diseases 2019, Amsterdam, the Netherlands. Abstract #2938 and poster #P2615.

mariAST® methodology enables high precision MIC testing. Antikainen P, et al. 36th Annual meeting of the Nordic Society of Clinical Microbiology and Infectious Diseases 2019, Trondheim, Norwey . Abstract and poster # P-19, 67782.

mariAST methodology for real-time and rapid phenotypic AST enables species-specific detection directly from clinical samples down to 1 CFU/well. Antikainen P, et al. 27th European Congress of Clinical Microbiology and Infectious Diseases 2017, Vienna, Austria. Abstract #4771 and poster #P0172.

mariAST® in-well culture methodology for direct, real-time and rapid phenotypic AST enables bacterial detection down to 1 CFU/well. Antikainen P, et al. 33th Annual meeting of Nordic Society of Clinical Microbiology and Infectious Diseases 2016, Rovaniemi, Finland. Abstract and poster #049.

High-throughput screening of colonization samples for methicillin-resistant Staphylococcus aureus. Stenholm T, et al. Scand J Infect Dis. (2013) 45:922–9.

Evaluation of the TPX MRSA assay for the detection of methicillin-resistant Staphylococcus aureus. Stenholm T, et al. Eur J Clin Microbiol Infect Dis (2011) 30:1237–43.

Development of a rapid assay methodology for antimicrobial susceptibility testing of Staphylococcus aureus. Koskinen JO, et al. Diagn Microbiol Infect Dis. (2008) 62:306–16.